The Oncosearch | Oncotarget

Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes Research Paper

Olga Y. Gorlova, Marek Kimmel, Spiridon Tsavachidis, Christopher I. Amos, Ivan P. Gorlov

Published May 6, 2022 · Vol. 13, No. 1 · pp. 756-767

Keywords: lung cancer, somatic mutations, driver genes, Catalog Of Somatic Mutations In Cancer (COSMIC)

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Research Paper

Carolina Sciortino, Valentina Viglialoro, Massimo Nucci, Mariam Grazia Polito, Enrico Cortesi, Alain Gelibter, Paola Gazzaniga, Chiara Nicolazzo, Marco Siringo, Salvatore Caponnetto

Published Apr 29, 2022 · Vol. 13, No. 1 · pp. 686-693

Keywords: NSCLC, immunotherapy, KRAS G12C mutation, liquid biopsy

Correction: Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma Correction

Yang Song, Bing Sun, LiHong Hao, Jun Hu, Sha Du, Xin Zhou, LiYuan Zhang, Lu Liu, LinLin Gong, XinMing Chi, Qiang Liu, ShuJuan Shao

Published Mar 15, 2022

Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification Correction

Yu Zhang, Zu-Yun Li, Xin-Xi Hou, Xiao Wang, Yi-Huan Luo, Yan-Ping Ying, Gang Chen

Published Feb 26, 2022 · Vol. 13, No. 1 · pp. 518-520

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations Review

Antonio Marchetti, Fiamma Buttitta, Emanuela D’Angelo

Published Feb 25, 2022 · Vol. 13, No. 1 · pp. 456-463

Keywords: non-small cell lung cancer, osimertinib, diagnostics, early, survival

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer Review

Alexander W. Pohlman, Hita Moudgalya, Lia Jordano, Gabriela C. Lobato, David Gerard, Michael J. Liptay, Christopher W. Seder, Jeffrey A. Borgia

Published Feb 15, 2022 · Vol. 13, No. 1 · pp. 393-407

Keywords: IGF, lung cancer, biomarkers, screening, prognostication

PACER lncRNA regulates COX-2 expression in lung cancer cells Research Paper

Samuel Z. Desind, Joseph R. Iacona, Christina Y. Yu, Antonina Mitrofanova, Carol S. Lutz

Published Jan 29, 2022 · Vol. 13, No. 1 · pp. 291-306

Keywords: PACER, COX-2, PGE₂, lung adenocarcinoma, inflammation

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Ami N. Shah, Ashwin Sunderraj, Brian Finkelman, Sharlene H. See, Andrew A. Davis, Lorenzo Gerratana, Firas Wehbe, Neelima Katam, Deva Mahalingam, William J. Gradishar, Amir Behdad, Luis Blanco, Massimo Cristofanilli

Published Jan 26, 2022 · Vol. 13, No. 1 · pp. 273-280

Keywords: ERBB2, HER2, next-generation sequencing, copy number gain, circulating tumor DNA

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Research Paper

Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, David Stenehjem

Published Jan 7, 2022 · Vol. 13, No. 1 · pp. 257-270

Keywords: lung neoplasma, tumor biomarkers, immunotherapy

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Timothy Craig Allen, Yan Xiao, Baiyu Yang, Denise Croix, Anup Abraham, Stella Redpath, Julia Engstrom-Melynk, Roma Shah, Jaya Madala, Eric H. Bernicker

Published Dec 23, 2021

Keywords: ALK rearrangement, NSCLC, prevalence

TEST: Please ignore this paper: Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Timothy Craig Allen, Yan Xiao, Baiyu Yang, Denise Croix, Anup Abraham, Stella Redpath, Julia Engstrom-Melynk, Roma Shah, Jaya Madala, Eric H. Bernicker

Published Dec 17, 2021

Keywords: ALK rearrangement, NSCLC, prevalence

Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models Research Paper

Lindsay R. Stolzenburg, Barrett Ainsworth, Bridget Riley-Gillis, Tibor Pakozdi, Areej Ammar, Paul A. Ellis, Julie L. Wilsbacher, Cyril Y. Ramathal

Published Dec 17, 2021 · Vol. 13, No. 1 · pp. 1-12

Keywords: PARP inhibitor, veliparib, cisplatin, transcriptomics, NSCLC

Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition Correction

Xi Wei, Qing Li, Ying Li, Wei Duan, Chongbiao Huang, Xiangqian Zheng, Lei Sun, Jingtao Luo, Dong Wang, Sheng Zhang, Xiaojie Xin, Ming Gao

Published Nov 23, 2021 · Vol. 13, No. 1 · pp. 118-119

Optimization of tumor spheroid model in mesothelioma and lung cancers and anti-cancer drug testing in H2052/484 spheroids Research Paper

Dylan A.J. Gendre, Edis Ameti, Wolfram Karenovics, Nadja Perriraz-Mayer, Frédéric Triponez, Véronique Serre-Beinier

Published Nov 15, 2021 · Vol. 12, No. 24 · pp. 2375-2387

Keywords: cancer patient, lung tumor, pleura mesothelioma, tumor spheroid, chemosensitivity

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas Research Paper

Robert Hsu, Yasmine Baca, Joanne Xiu, Rongfu Wang, J. Nicholas Bodor, Chul Kim, Hina Khan, Hirva Mamdani, Misako Nagasaka, Sonam Puri, Stephen V. Liu, W. Michael Korn, Jorge J. Nieva

Published Nov 13, 2021 · Vol. 12, No. 25 · pp. 2449-2458

Keywords: lung cancer, tumor microenvironment, diagnostic biomarkers, biomarkers for immunotherapy, cancer testis antigen

Correction: Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status Correction

Jun Zhang, Sreenivas Nannapaneni, Dongsheng Wang, Fakeng Liu, Xu Wang, Rui Jin, Xiuju Liu, Mohammad Aminur Rahman, Xianghong Peng, Guoqing Qian, Zhuo G. Chen, Kwok-Kin Wong, Fadlo R. Khuri, Wei Zhou, Dong M. Shin

Published Nov 5, 2021

Correction: Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth Correction

Zsuzsanna Nemeth, Eva Csizmadia, Lisa Vikstrom, Mailin Li, Kavita Bisht, Alborz Feizi, Sherrie Otterbein, Brian Zuckerbraun, Daniel B. Costa, Pier Paolo Pandolfi, Janos Fillinger, Balazs Döme, Leo E. Otterbein, Barbara Wegiel

Published Nov 3, 2021

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Timothy Craig Allen, Yan Xiao, Baiyu Yang, Denise Croix, Anup Abraham, Stella Redpath, Julia Engstrom-Melynk, Roma Shah, Jaya Madala, Eric H. Bernicker

Published Oct 29, 2021 · Vol. 12, No. 23 · pp. 2308-2315

Keywords: ALK rearrangement, NSCLC, prevalence

Correction: NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling Correction

Cuixiang Zhang, Tian Lan, Jincai Hou, Juan Li, Rende Fang, Zhicheng Yang, Min Zhang, Jianxun Liu, Bing Liu

Published Oct 28, 2021

Correction: PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma Correction

Wei-Ren Liu, Meng-Xin Tian, Liu-Xiao Yang, Yu-Li Lin, Lei Jin, Zhen-Bin Ding, Ying-Hao Shen, Yuan-Fei Peng, Dong-Mei Gao, Jian Zhou, Shuang-Jian Qiu, Zhi Dai, Rui He, Jia Fan, Ying-Hong Shi

Published Oct 28, 2021

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes Research Paper

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Research Paper

Correction: Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma Correction

Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification Correction

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations Review

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer Review

PACER lncRNA regulates COX-2 expression in lung cancer cells Research Paper

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Research Paper

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

TEST: Please ignore this paper: Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models Research Paper

Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition Correction

Optimization of tumor spheroid model in mesothelioma and lung cancers and anti-cancer drug testing in H2052/484 spheroids Research Paper

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas Research Paper

Correction: Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status Correction

Correction: Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth Correction

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Correction: NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling Correction

Correction: PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma Correction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes Research Paper

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Research Paper

Correction: Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma Correction

Correction: Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification Correction

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations Review

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer Review

PACER lncRNA regulates COX-2 expression in lung cancer cells Research Paper

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Research Paper

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

TEST: Please ignore this paper: Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models Research Paper

Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition Correction

Optimization of tumor spheroid model in mesothelioma and lung cancers and anti-cancer drug testing in H2052/484 spheroids Research Paper

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas Research Paper

Correction: Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status Correction

Correction: Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth Correction

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data Research Paper

Correction: NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling Correction

Correction: PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma Correction